Antiscalants Market - Global Forecast to 2029
| 出版社 | MarketsandMarkets |
| 出版年月 | 2024年9月 |
| ページ数 | 282 |
| 図表数 | 316 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
Report Overview
The Antiscalants market size is projected to grow from USD 4.5 billion in 2024 to USD 5.9 billion by 2029, registering a CAGR of 5.4% during the forecast period in terms of value.
スケール防止剤の市場規模は、2024年の45億米ドルから2029年までに59億米ドルに成長すると予測されており、金額ベースで予測期間中に5.4%のCAGRを記録します。
The global antiscalants market is witnessing growth due to its versatile properties and it is also widely used in various industries due to its exceptional properties such as delaying nucleation, distorting crystal structure, reducing the precipitation rate. Furthermore, antiscalants are required for the application in water treatment and desalination, which drives the antiscalants industry.
“Carboxylates/Carbonates are projected to be the second fastest growing type in terms of value.”
Carboxylates/Carbonates are projected to be the second fastest growing type in the antiscalants market due to several factors. As Carboxylic scale inhibitors possess good scale control efficiency compared to calcium-based salt scales under extreme temperatures, water hardness, and a varied pH range. Mono or dicarboxylic acids, phosphine carboxylic acid, anhydrides, and acrylic co/terpolymers are carboxylates/carbonate antiscalants used to inhibit scale. They are used in water treatment scaling applications and boiler water hardness treatment. The presence of hypochlorite makes them more stable than other antiscalant types. They hold high thermal stability and vigorous dispersant activity, enabling them to control scale build-up in high-temperature oil fields and mining operations.
“Threshold inhibitors process type is expected to account for the largest market share in 2023 in terms of value.”
Threshold inhibitors process type is expected to account for the largest share in 2023 in terms of value. The threshold inhibitors operate on the principle of delaying the crystal formation process by using scale inhibitors in low concentrations, hence finding favor economically. Threshold inhibitors work on the principle of the adsorption mechanism. Scale formation begins with ion clusters in the solution that come up with an orientation and finally yield micro-crystallites. Once a new crystal begins growing, it can either grow larger or dissolve into the solution. As the scale starts to form around these tiny crystals, the inhibitors in the threshold also attach themselves to the surface of the crystals, preventing their further growth. This makes the crystal unstable and perform dissolution, while releasing the inhibitor in order to stop another crystal from growing.
“Europe is estimated to be the third-largest market for antiscalants in terms of value for the forecasted period.”
Europe holds a significant position as the third-largest region in the global antiscalants market, driven by several factors such as the European market for antiscalants is quite mature, primarily due to the gradual shift of the manufacturing sector to countries with high demand and lower production costs. Despite the economic downturn in Europe, the food & beverage industry in the region registered a slightly higher growth rate than the overall manufacturing industry in the region during the past decade. The requirement for improved water quality for different industrial processes, coupled with stringent regulations regarding the treatment and disposal of polluted water, are the major factors driving this market. Steady population growth and increasing standard of living are driving the medical & pharmaceutical, water & wastewater treatment, and industrial filtration industries in the region.
In-depth interviews were conducted with Chief Executive Officers (CEOs), marketing directors, other innovation and technology directors, and executives from various key organizations operating in the antiscalants market, and information was gathered from secondary research to determine and verify the market size of several segments.
- By Company Type: Tier 1 – 40%, Tier 2 – 30%, and Tier 3 – 30%
- By Designation: C Level Executives– 20%, Directors – 10%, and Others – 70%
- By Region: North America – 20%, Europe – 20%, APAC – 40%, South America- 10% , and the Middle East & Africa –10%
The Antiscalants market comprises major players such as Dow (US), BASF SE (Germany), Ecolab (US), Solenis (US), Kemira (Finland), Kurita Water Industries Ltd. (Japan), Syensqo (Belgium), Clariant (Switzerland), Veolia (France), Italmatch Chemicals S.p.A (Italy). The study includes in-depth competitive analysis of these key players in the antiscalants market, with their company profiles, recent developments, and key market strategies.
Research Coverage
This report segments the market for antiscalants market on the basis of type, application, process type, and region, and provides estimations for the overall value of the market across various regions. A detailed analysis of key industry players has been conducted to provide insights into their business overviews, products & services, key strategies, new product launches, expansions, and mergers & acquisition associated with the market for antiscalants market.
Key benefits of buying this report
This research report is focused on various levels of analysis — industry analysis (industry trends), market ranking analysis of top players, and company profiles, which together provide an overall view on the competitive landscape; emerging and high-growth segments of the antiscalants market; high-growth regions; and market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the antiscalants market offered by top players in the global antiscalants market.
- Analysis of drivers: (High growth in application in end use industries, Stringent water treatment regulations) restraints (Volatility in cost of raw materials), opportunities (Increasing use of antiscalants in oil & gas applications, Biodegradability of antiscalants) and challenges (Potential of membrane fouling, a threat to growing market)
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the antiscalants market.
- Market Development: Comprehensive information about lucrative emerging markets — the report analyzes the markets for antiscalants market across regions.
- Market Capacity: Production capacities of companies producing antiscalants are provided wherever available with upcoming capacities for the antiscalants market.
- Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of leading players in the antiscalants market.
Table of Contents
1 INTRODUCTION 24
1.1 STUDY OBJECTIVES 24
1.2 MARKET DEFINITION 24
1.3 STUDY SCOPE 25
1.3.1 MARKETS AND REGIONS COVERED 25
1.3.2 INCLUSIONS AND EXCLUSIONS 26
1.3.3 YEARS CONSIDERED 27
1.3.4 CURRENCY CONSIDERED 27
1.3.5 UNITS CONSIDERED 27
1.4 STAKEHOLDERS 27
1.5 SUMMARY OF CHANGES 28
2 RESEARCH METHODOLOGY 30
2.1 RESEARCH DATA 30
2.1.1 SECONDARY DATA 31
2.1.1.1 Key secondary sources 31
2.1.1.2 Key data from secondary sources 31
2.1.2 PRIMARY DATA 32
2.1.2.1 Key data from primary sources 33
2.1.2.2 Key industry insights 33
2.1.2.3 Breakdown of interviews with experts 34
2.2 MARKET SIZE ESTIMATION 34
2.2.1 BOTTOM-UP APPROACH 35
2.2.2 TOP-DOWN APPROACH 36
2.3 DATA TRIANGULATION 37
2.4 RESEARCH ASSUMPTIONS 38
2.5 FACTOR ANALYSIS 38
2.6 GROWTH FORECAST 38
2.6.1 SUPPLY SIDE 39
2.6.2 DEMAND SIDE 39
2.7 RESEARCH LIMITATIONS 39
2.8 RISK ASSESSMENT 39
3 EXECUTIVE SUMMARY 40
4 PREMIUM INSIGHTS 45
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN ANTISCALANTS MARKET 45
4.2 ANTISCALANTS MARKET, BY TYPE 45
4.3 ANTISCALANTS MARKET, BY APPLICATION 46
4.4 ANTISCALANTS MARKET, BY PROCESS TYPE 47
4.5 ANTISCALANTS MARKET, BY APPLICATION AND REGION 47
4.6 ANTISCALANTS MARKET, BY KEY COUNTRY 48
5 MARKET OVERVIEW 49
5.1 INTRODUCTION 49
5.2 IMPACT OF AI/GEN AI 49
5.2.1 INTRODUCTION 49
5.2.2 OVERVIEW OF IMPACT 49
5.2.2.1 NEERO System, remote monitoring and predictive maintenance solution for reverse osmosis 49
5.2.2.2 Rise of AI and ML algorithms helping in antiscalant testing 49
5.2.2.3 AI/GenAI impact on reverse osmosis 50
5.3 MARKET DYNAMICS 50
5.3.1 DRIVERS 51
5.3.1.1 High growth in applications in end-use industries 51
5.3.1.2 Declining global availability of water, along with increasing demand for clean water 51
5.3.1.3 Stringent water treatment regulations 52
5.3.2 RESTRAINTS 52
5.3.2.1 Volatility in costs of raw materials 52
5.3.3 OPPORTUNITIES 53
5.3.3.1 Increasing use of antiscalants in oil & gas applications 53
5.3.3.2 Biodegradability of antiscalants 53
5.3.4 CHALLENGES 53
5.3.4.1 Potential of membrane fouling threat to growing market 53
5.4 PORTER’S FIVE FORCES ANALYSIS 54
5.4.1 THREAT OF SUBSTITUTES 55
5.4.2 BARGAINING POWER OF SUPPLIERS 55
5.4.3 THREAT OF NEW ENTRANTS 55
5.4.4 BARGAINING POWER OF BUYERS 55
5.4.5 INTENSITY OF COMPETITIVE RIVALRY 56
5.5 KEY STAKEHOLDERS AND BUYING CRITERIA 56
5.5.1 KEY STAKEHOLDERS IN BUYING PROCESS 56
5.5.2 BUYING CRITERIA 57
5.6 VALUE CHAIN ANALYSIS 58
5.7 MACROECONOMIC INDICATORS 59
5.7.1 GLOBAL GDP TRENDS 59
5.8 ECOSYSTEM ANALYSIS 61
5.9 CASE STUDY ANALYSIS 62
5.9.1 HUBER GROUP’S USE OF TORAY RUPER ANTISCALANT 62
5.9.2 COMBATING IRON FOULING IN BRACKISH WATER RO SYSTEMS 63
5.9.3 IMPACT OF ROPUR RPI ANTISCALANT AT LOHNEN WATER PLANT 63
5.10 REGULATORY LANDSCAPE 64
5.10.1 REGULATIONS 64
5.10.1.1 North America 64
5.10.1.2 Asia Pacific 65
5.10.1.3 Europe 66
5.10.1.4 Middle East & Africa 68
5.10.1.5 South America 69
5.10.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 70
5.11 TECHNOLOGY ANALYSIS 74
5.11.1 KEY TECHNOLOGIES 74
5.11.1.1 Squeeze treatment for antiscalants 74
5.11.1.2 Continuous injection system 74
5.11.2 COMPLEMENTARY TECHNOLOGIES 74
5.11.2.1 Extended-release scale inhibitor technology 74
5.11.2.2 Biodegradable antiscalant technology 75
5.11.2.3 Dendrimer-based antiscalant technology 75
5.11.3 ADJACENT TECHNOLOGIES 75
5.11.3.1 Electrolytic technology 75
5.11.3.2 Electrochemical technology for scale inhibition 76
5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 76
5.13 TRADE ANALYSIS (EXPORT/IMPORT)- VOLUME AND TRADE PRICES 77
5.13.1 TRADE ANALYSIS 77
5.14 KEY CONFERENCES AND EVENTS, 2024–2025 79
5.15 PRICING ANALYSIS 80
5.15.1 FACTORS AFFECTING PRICES 80
5.15.2 AVERAGE SELLING PRICE TREND BY REGION 81
5.15.3 AVERAGE SELLING PRICE, BY TYPE 82
5.15.4 AVERAGE SELLING PRICE, BY APPLICATION 82
5.15.5 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY APPLICATION 83
5.16 INVESTMENT AND FUNDING SCENARIO 84
5.17 PATENT ANALYSIS 84
5.17.1 METHODOLOGY 84
5.17.2 DOCUMENT TYPE 84
5.17.3 PUBLICATION TRENDS – LAST 10 YEARS 85
5.17.4 INSIGHTS 86
5.17.5 TOP 10 COMPANIES/APPLICANTS 87
5.17.6 PATENTS BY ECOLAB 87
5.17.7 PATENTS BY KEMIRA 88
5.17.8 PATENTS BY BASF SE 88
5.17.9 TOP 10 PATENT OWNERS IN LAST 10 YEARS 89
6 ANTISCALANTS MARKET, BY TYPE 90
6.1 INTRODUCTION 91
6.2 PHOSPHONATES 93
6.2.1 EXTENSIVE UTILIZATION OF PHOSPHONATES IN WATER TREATMENT AND DESALINATION INDUSTRY TO DRIVE MARKET 93
6.3 CARBOXYLATES/CARBONATES 93
6.3.1 CONTROL OF SCALE BUILDUP IN HIGH-TEMPERATURE OIL FIELDS AND MINING OPERATIONS TO PROPEL MARKET 93
6.4 SULFONATES 94
6.4.1 USE IN OIL & GAS SECTOR FOR DOWNHOLE CHEMICAL INJECTION AND SQUEEZE OPERATION TO DRIVE MARKET 94
6.5 FLUORIDES 94
6.5.1 REMOVAL OF CHALLENGING SILICATE DEPOSITS IN INDUSTRIAL WATER SYSTEMS TO BOOST MARKET 94
6.6 OTHER TYPES 94
7 ANTISCALANTS MARKET, BY PROCESS TYPE 95
7.1 INTRODUCTION 96
7.2 THRESHOLD INHIBITOR 98
7.2.1 ECONOMIC ATTRACTIVENESS DUE TO LOW COST TO BOOST MARKET 98
7.3 CRYSTAL MODIFICATION 98
7.3.1 DEMAND FOR ADVANCED SOLUTIONS IN OIL & GAS, POWER GENERATION, WATER TREATMENT, AND MINING SECTORS TO DRIVE MARKET 98
7.4 DISPERSION 99
7.4.1 COMPATIBILITY WITH OTHER WATER TREATMENT CHEMICALS ENABLING INTEGRATED SOLUTIONS TO PROPEL MARKET 99
7.5 OTHER PROCESS TYPES 99
8 ANTISCALANTS MARKET, BY APPLICATION 100
8.1 INTRODUCTION 101
8.2 POWER & CONSTRUCTION 104
8.2.1 MAINTAINING EQUIPMENT EFFICIENCY AND LIFETIME TO DRIVE MARKET 104
8.3 MINING 104
8.3.1 MITIGATION OF SCALE DEPOSITION IN PIPELINES, DRILLING EQUIPMENT, AND PROCESSING FACILITIES TO BOOST MARKET 104
8.4 OIL & GAS 105
8.4.1 CONTINUOUS PRODUCTION AT OPTIMUM PERFORMANCE AND EFFICIENCY TO PROPEL MARKET GROWTH 105
8.5 MUNICIPAL WATER TREATMENT & DESALINATION 105
8.5.1 REDUCTION IN REQUIREMENT FOR MEMBRANE CLEANING AND OPERATIONAL COSTS TO DRIVE MARKET 105
8.6 FOOD & BEVERAGE 106
8.6.1 EFFICIENCY OF BOILERS, COOLERS, AND SINGLE- AND MULTIPLE-EFFECT EVAPORATORS TO BOOST MARKET 106
8.7 CHEMICAL & PHARMACEUTICAL 106
8.7.1 ACHIEVING OPTIMUM FLOW RATES TO ENABLE PRODUCTIVITY AND HEAT TRANSFER EFFICIENCY TO PROPEL MARKET 106
8.8 PULP & PAPER 106
8.8.1 IMPROVED PAPER QUALITY TO DRIVE MARKET 106
8.9 OTHER APPLICATIONS 107
8.9.1 TEXTILE 107
8.9.2 LEATHER TANNING 107
8.9.3 INDUSTRIAL & INSTITUTIONAL CLEANING 107
8.9.4 HOME CARE 107
8.9.5 ETHANOL PRODUCTION 107
8.9.6 AGRICULTURE 107
9 ANTISCALANTS MARKET, BY REGION 108
9.1 INTRODUCTION 109
9.2 NORTH AMERICA 111
9.2.1 US 117
9.2.1.1 Increase in oil production activities and rising demand for potable drinking water to drive market 117
9.2.2 CANADA 119
9.2.2.1 Increase in food processing establishments to drive market 119
9.2.3 MEXICO 122
9.2.3.1 Growth of manufacturing sector to boost market 122
9.3 EUROPE 124
9.3.1 GERMANY 131
9.3.1.1 Maintenance of high treatment standards and environmental integrity to fuel market growth 131
9.3.2 ITALY 133
9.3.2.1 Demand from water-intensive industries to drive market 133
9.3.3 FRANCE 136
9.3.3.1 Well-developed industrial infrastructure to lead to market growth 136
9.3.4 UK 138
9.3.4.1 Government focus on sustainability to support market 138
9.3.5 SPAIN 141
9.3.5.1 Surge in demand for desalinated water to drive market 141
9.3.6 REST OF EUROPE 143
9.4 ASIA PACIFIC 146
9.4.1 CHINA 152
9.4.1.1 Demand from oil & gas and mining sectors to drive market 152
9.4.2 JAPAN 155
9.4.2.1 Growth of chemical & pharmaceutical industries to boost demand. 155
9.4.3 SOUTH KOREA 158
9.4.3.1 Government initiatives to promote developments in technology and manufacturing activities to boost market 158
9.4.4 INDIA 160
9.4.4.1 Consistently increasing manufacturing output to fuel market growth 160
9.4.5 REST OF ASIA PACIFIC 163
9.5 MIDDLE EAST & AFRICA 166
9.5.1 GCC COUNTRIES 171
9.5.2 SAUDI ARABIA 172
9.5.2.1 Government initiatives for desalinated water to boost consumption 172
9.5.3 QATAR 174
9.5.3.1 Reverse osmosis desalination for sea water to contribute to significant demand 174
9.5.4 UAE 177
9.5.4.1 Increasing demand from end-use industries to lead to significant growth 177
9.5.5 REST OF GCC 180
9.5.6 REST OF MIDDLE EAST & AFRICA 182
9.6 SOUTH AMERICA 185
9.6.1 BRAZIL 190
9.6.1.1 Expanding textile industry and oil & gas exploration to drive market 190
9.6.2 ARGENTINA 193
9.6.2.1 Growing construction sector to propel market 193
9.6.3 REST OF SOUTH AMERICA 195
10 COMPETITIVE LANDSCAPE 198
10.1 INTRODUCTION 198
10.2 KEY PLAYER STRATEGIES 199
10.3 MARKET SHARE ANALYSIS 202
10.4 REVENUE ANALYSIS 203
10.5 COMPANY VALUATION AND FINANCIAL METRICS 205
10.6 BRAND/PRODUCT COMPARISON 206
10.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 207
10.7.1 STARS 207
10.7.2 EMERGING LEADERS 207
10.7.3 PERVASIVE PLAYERS 207
10.7.4 PARTICIPANTS 207
10.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 209
10.7.5.1 Company footprint 209
10.7.5.2 Type footprint 210
10.7.5.3 Application footprint 211
10.7.5.4 Process type footprint 212
10.7.5.5 Region footprint 213
10.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 214
10.8.1 PROGRESSIVE COMPANIES 214
10.8.2 RESPONSIVE COMPANIES 214
10.8.3 DYNAMIC COMPANIES 214
10.8.4 STARTING BLOCKS 214
10.8.5 COMPETITIVE BENCHMARKING 216
10.8.5.1 Detailed list of key startups/SMEs 216
10.8.5.2 Competitive benchmarking of key startups/SMEs 217
10.9 COMPETITIVE SCENARIO AND TRENDS 218
10.9.1 PRODUCT LAUNCHES 218
10.9.2 DEALS 218
10.9.3 EXPANSIONS 220
10.10 COMPETITIVE LANDSCAPE: ANTISCALANTS IN MIDDLE EAST 223
11 COMPANY PROFILES 224
11.1 KEY PLAYERS 224
11.1.1 DOW 224
11.1.1.1 Business overview 224
11.1.1.2 Products/Solutions/Services offered 225
11.1.1.3 MnM view 226
11.1.1.3.1 Right to win 226
11.1.1.3.2 Strategic choices 226
11.1.1.3.3 Weaknesses and competitive threats 227
11.1.2 BASF SE 228
11.1.2.1 Business overview 228
11.1.2.2 Products/Solutions/Services offered 229
11.1.2.3 MnM view 230
11.1.2.3.1 Right to win 230
11.1.2.3.2 Strategic choices 230
11.1.2.3.3 Weaknesses and competitive threats 231
11.1.3 ECOLAB 232
11.1.3.1 Business overview 232
11.1.3.2 Products/Solutions/Services offered 233
11.1.3.3 Recent developments 234
11.1.3.3.1 Deals 234
11.1.3.3.2 Other developments 234
11.1.3.4 MnM view 234
11.1.4 SOLENIS 235
11.1.4.1 Business overview 235
11.1.4.2 Products/Solutions/Services offered 236
11.1.4.3 Recent developments 237
11.1.4.3.1 Deals 237
11.1.4.4 MnM view 238
11.1.5 KEMIRA 239
11.1.5.1 Business overview 239
11.1.5.2 Products/Solutions/Services offered 240
11.1.5.3 Recent developments 241
11.1.5.3.1 Deals 241
11.1.5.3.2 Expansions 241
11.1.5.4 MnM view 242
11.1.5.4.1 Right to win 242
11.1.5.4.2 Strategic choices 242
11.1.5.4.3 Weaknesses and competitive threats 242
11.1.6 CLARIANT 243
11.1.6.1 Business overview 243
11.1.6.2 Products/Solutions/Services offered 244
11.1.6.3 Recent developments 245
11.1.6.3.1 Expansions 245
11.1.6.4 MnM view 245
11.1.6.4.1 Right to win 245
11.1.6.4.2 Strategic choices 246
11.1.6.4.3 Weaknesses and competitive threats 246
11.1.7 SYENSQO 247
11.1.7.1 Business overview 247
11.1.7.2 Products/Solutions/Services offered 248
11.1.7.3 Recent developments 250
11.1.7.3.1 Deals 250
11.1.7.4 MnM view 250
11.1.8 KURITA WATER INDUSTRIES LTD. 251
11.1.8.1 Business overview 251
11.1.8.2 Products/Solutions/Services offered 252
11.1.8.3 Recent developments 253
11.1.8.3.1 Expansions 253
11.1.8.4 MnM view 253
11.1.9 VEOLIA GROUP 254
11.1.9.1 Business overview 254
11.1.9.2 Products/Solutions/Services offered 255
11.1.9.3 Recent developments 256
11.1.9.3.1 Deals 256
11.1.9.3.2 Expansions 257
11.1.9.4 MnM view 257
11.1.9.4.1 Right to win 257
11.1.9.4.2 Strategic choices 258
11.1.9.4.3 Weaknesses and competitive threats 258
11.1.10 ITALMATCH CHEMICALS S.P.A. 259
11.1.10.1 Business overview 259
11.1.10.2 Products/Solutions/Services offered 260
11.1.10.3 Recent developments 262
11.1.10.3.1 Product launches 262
11.1.10.3.2 Deals 263
11.1.10.4 MnM view 263
11.2 OTHER PLAYERS (MIX OF GLOBAL AND REGIONAL PLAYERS HAVING PRESENCE MOSTLY IN GCC AND MIDDLE EAST REGION) 264
11.2.1 BIOLAB ARABIA LTD. CO. 264
11.2.2 DUBICHEM 265
11.2.3 BAKER HUGHES COMPANY 266
11.2.4 REZA INVESTMENT COMPANY LTD. 267
11.2.5 NOURYON 268
11.2.6 ARIES CHEMICAL, INC. 268
11.2.7 OVIVO 269
11.2.8 WEATHERFORD 270
11.2.9 REDA WATER 271
11.2.10 METITO 271
11.2.11 AES ARABIA LTD. 272
11.2.12 SNF GROUP 272
11.2.13 ARKEMA 273
11.2.14 ANGEL CHEMICALS PRIVATE LIMITED 274
11.2.15 HYDROVIDA 274
12 APPENDIX 275
12.1 DISCUSSION GUIDE 275
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 278
12.3 CUSTOMIZATION OPTIONS 280
12.4 RELATED REPORTS 280
12.5 AUTHOR DETAILS 281
LIST OF TABLES
TABLE 1 ANTISCALANTS MARKET: INCLUSIONS AND EXCLUSIONS 26
TABLE 2 INTERVIEWS WITH EXPERTS – DEMAND AND SUPPLY SIDES 32
TABLE 3 ANTISCALANTS MARKET: PORTER’S FIVE FORCES ANALYSIS 54
TABLE 4 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY APPLICATION (%) 56
TABLE 5 KEY BUYING CRITERIA, BY APPLICATION 57
TABLE 6 TREND OF PER CAPITA GDP, BY COUNTRY, 2020–2023 (USD) 59
TABLE 7 GDP GROWTH ESTIMATES AND PROJECTIONS OF KEY COUNTRIES,
2024–2027 (USD) 60
TABLE 8 ROLES OF COMPANIES IN ANTISCALANT ECOSYSTEM 62
TABLE 9 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 70
TABLE 10 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 71
TABLE 11 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 71
TABLE 12 MIDDLE EAST & AFRICA: REGULATORY BODIES, AGENCIES, AND ORGANIZATIONS 72
TABLE 13 SOUTH AMERICA: REGULATORY BODIES, AGENCIES, AND ORGANIZATIONS 73
TABLE 14 ANTISCALANTS MARKET: KEY CONFERENCES AND EVENTS, 2024–2025 79
TABLE 15 ANTISCALANTS MARKET, BY TYPE, 2020–2023 (KILOTON) 91
TABLE 16 ANTISCALANTS MARKET, BY TYPE, 2024–2029 (KILOTON) 92
TABLE 17 ANTISCALANTS MARKET, BY TYPE, 2020–2023 (USD MILLION) 92
TABLE 18 ANTISCALANTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 92
TABLE 19 ANTISCALANTS MARKET, BY PROCESS TYPE, 2020–2023 (KILOTON) 96
TABLE 20 ANTISCALANTS MARKET, BY PROCESS TYPE, 2024–2029 (KILOTON) 97
TABLE 21 ANTISCALANTS MARKET, BY PROCESS TYPE, 2020–2023 (USD MILLION) 97
TABLE 22 ANTISCALANTS MARKET, BY PROCESS TYPE, 2024–2029 (USD MILLION) 97
TABLE 23 ANTISCALANTS MARKET, BY APPLICATION, 2020–2023 (KILOTON) 102
TABLE 24 ANTISCALANTS MARKET, BY APPLICATION, 2024–2029 (KILOTON) 102
TABLE 25 ANTISCALANTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 103
TABLE 26 ANTISCALANTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 103
TABLE 27 ANTISCALANTS MARKET, BY REGION, 2020–2023 (KILOTON) 109
TABLE 28 ANTISCALANTS MARKET, BY REGION, 2024–2029 (KILOTON) 110
TABLE 29 ANTISCALANTS MARKET, BY REGION, 2020–2023 (USD MILLION) 110
TABLE 30 ANTISCALANTS MARKET, BY REGION, 2024–2029 (USD MILLION) 110
TABLE 31 NORTH AMERICA: ANTISCALANTS MARKET, BY COUNTRY, 2020–2023 (KILOTON) 112
TABLE 32 NORTH AMERICA: ANTISCALANTS MARKET, BY COUNTRY, 2024–2029 (KILOTON) 112
TABLE 33 NORTH AMERICA: ANTISCALANTS MARKET, BY COUNTRY,
2020–2023 (USD MILLION) 112
TABLE 34 NORTH AMERICA: ANTISCALANTS MARKET, BY COUNTRY,
2024–2029 (USD MILLION) 112
TABLE 35 NORTH AMERICA ANTISCALANTS MARKET, BY TYPE, 2020–2023 (KILOTON) 113
TABLE 36 NORTH AMERICA ANTISCALANTS MARKET, BY TYPE, 2024–2029 (KILOTON) 113
TABLE 37 NORTH AMERICA ANTISCALANTS MARKET, BY TYPE, 2020–2023 (USD MILLION) 113
TABLE 38 NORTH AMERICA ANTISCALANTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 114
TABLE 39 NORTH AMERICA ANTISCALANTS MARKET, BY PROCESS TYPE,
2020–2023 (KILOTON) 114
TABLE 40 NORTH AMERICA ANTISCALANTS MARKET, BY PROCESS TYPE,
2024–2029 (KILOTON) 114
TABLE 41 NORTH AMERICA ANTISCALANTS MARKET, BY PROCESS TYPE,
2020–2023 (USD MILLION) 115
TABLE 42 NORTH AMERICA ANTISCALANTS MARKET, BY PROCESS TYPE,
2024–2029 (USD MILLION) 115
TABLE 43 NORTH AMERICA: ANTISCALANTS MARKET, BY APPLICATION,
2020–2023 (KILOTON) 115
TABLE 44 NORTH AMERICA: ANTISCALANTS MARKET, BY APPLICATION,
2024–2029 (KILOTON) 116
TABLE 45 NORTH AMERICA: ANTISCALANTS MARKET, BY APPLICATION,
2020–2023 (USD MILLION) 116
TABLE 46 NORTH AMERICA: ANTISCALANTS MARKET, BY APPLICATION,
2024–2029 (USD MILLION) 116
TABLE 47 US: ANTISCALANTS MARKET, BY APPLICATION, 2020–2023 (KILOTON) 117
TABLE 48 US: ANTISCALANTS MARKET, BY APPLICATION, 2024–2029 (KILOTON) 118
TABLE 49 US: ANTISCALANTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 118
TABLE 50 US: ANTISCALANTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 119
TABLE 51 CANADA: ANTISCALANTS MARKET, BY APPLICATION, 2020–2023 (KILOTON) 120
TABLE 52 CANADA: ANTISCALANTS MARKET, BY APPLICATION, 2024–2029 (KILOTON) 120
TABLE 53 CANADA: ANTISCALANTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 121
TABLE 54 CANADA: ANTISCALANTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 121
TABLE 55 MEXICO: ANTISCALANTS MARKET, BY APPLICATION, 2020–2023 (KILOTON) 122
TABLE 56 MEXICO: ANTISCALANTS MARKET, BY APPLICATION, 2024–2029 (KILOTON) 123
TABLE 57 MEXICO: ANTISCALANTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 123
TABLE 58 MEXICO: ANTISCALANTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 124
TABLE 59 EUROPE: ANTISCALANTS MARKET, BY COUNTRY, 2020–2023 (KILOTON) 125
TABLE 60 EUROPE: ANTISCALANTS MARKET, BY COUNTRY, 2024–2029 (KILOTON) 126
TABLE 61 EUROPE: ANTISCALANTS MARKET, BY COUNTRY, 2020–2023 (USD MILLION) 126
TABLE 62 EUROPE: ANTISCALANTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 126
TABLE 63 EUROPE: ANTISCALANTS MARKET, BY TYPE, 2020–2023 (KILOTON) 127
TABLE 64 EUROPE: ANTISCALANTS MARKET, BY TYPE, 2024–2029 (KILOTON) 127
TABLE 65 EUROPE: ANTISCALANTS MARKET, BY TYPE, 2020–2023 (USD MILLION) 127
TABLE 66 EUROPE: ANTISCALANTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 128
TABLE 67 EUROPE: ANTISCALANTS MARKET, BY PROCESS TYPE, 2020–2023 (KILOTON) 128
TABLE 68 EUROPE: ANTISCALANTS MARKET, BY PROCESS TYPE, 2024–2029 (KILOTON) 128
TABLE 69 EUROPE: ANTISCALANTS MARKET, BY PROCESS TYPE, 2020–2023 (USD MILLION) 129
TABLE 70 EUROPE: ANTISCALANTS MARKET, BY PROCESS TYPE, 2024–2029 (USD MILLION) 129
TABLE 71 EUROPE: ANTISCALANTS MARKET, BY APPLICATION, 2020–2023 (KILOTON) 129
TABLE 72 EUROPE: ANTISCALANTS MARKET, BY APPLICATION, 2024–2029 (KILOTON) 130
TABLE 73 EUROPE: ANTISCALANTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 130
TABLE 74 EUROPE: ANTISCALANTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 130
TABLE 75 GERMANY: ANTISCALANTS MARKET, BY APPLICATION, 2020–2023 (KILOTON) 131
TABLE 76 GERMANY: ANTISCALANTS MARKET, BY APPLICATION, 2024–2029 (KILOTON) 132
TABLE 77 GERMANY: ANTISCALANTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 132
TABLE 78 GERMANY: ANTISCALANTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 133
TABLE 79 ITALY: ANTISCALANTS MARKET, BY APPLICATION, 2020–2023 (KILOTON) 134
TABLE 80 ITALY: ANTISCALANTS MARKET, BY APPLICATION, 2024–2029 (KILOTON) 134
TABLE 81 ITALY: ANTISCALANTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 135
TABLE 82 ITALY: ANTISCALANTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 135
TABLE 83 FRANCE: ANTISCALANTS MARKET, BY APPLICATION, 2020–2023 (KILOTON) 136
TABLE 84 FRANCE: ANTISCALANTS MARKET, BY APPLICATION, 2024–2029 (KILOTON) 137
TABLE 85 FRANCE: ANTISCALANTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 137
TABLE 86 FRANCE: ANTISCALANTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 138
TABLE 87 UK: ANTISCALANTS MARKET, BY APPLICATION, 2020–2023 (KILOTON) 139
TABLE 88 UK: ANTISCALANTS MARKET, BY APPLICATION, 2024–2029 (KILOTON) 139
TABLE 89 UK: ANTISCALANTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 140
TABLE 90 UK: ANTISCALANTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 140
TABLE 91 SPAIN: ANTISCALANTS MARKET, BY APPLICATION, 2020–2023 (KILOTON) 141
TABLE 92 SPAIN: ANTISCALANTS MARKET, BY APPLICATION, 2024–2029 (KILOTON) 142
TABLE 93 SPAIN: ANTISCALANTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 142
TABLE 94 SPAIN: ANTISCALANTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 143
TABLE 95 REST OF EUROPE: ANTISCALANTS MARKET, BY APPLICATION,
2020–2023 (KILOTON) 144
TABLE 96 REST OF EUROPE: ANTISCALANTS MARKET, BY APPLICATION,
2024–2029 (KILOTON) 144
TABLE 97 REST OF EUROPE: ANTISCALANTS MARKET, BY APPLICATION,
2020–2023 (USD MILLION) 145
TABLE 98 REST OF EUROPE: ANTISCALANTS MARKET, BY APPLICATION,
2024–2029 (USD MILLION) 145
TABLE 99 ASIA PACIFIC: ANTISCALANTS MARKET, BY COUNTRY, 2020–2023 (KILOTON) 147
TABLE 100 ASIA PACIFIC: ANTISCALANTS MARKET, BY COUNTRY, 2024–2029 (KILOTON) 148
TABLE 101 ASIA PACIFIC: ANTISCALANTS MARKET, BY COUNTRY, 2020–2023 (USD MILLION) 148
TABLE 102 ASIA PACIFIC: ANTISCALANTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 148
TABLE 103 ASIA PACIFIC: ANTISCALANTS MARKET, BY TYPE, 2020–2023 (KILOTON) 149
TABLE 104 ASIA PACIFIC: ANTISCALANTS MARKET, BY TYPE, 2024–2029 (KILOTON) 149
TABLE 105 ASIA PACIFIC: ANTISCALANTS MARKET, BY TYPE, 2020–2023 (USD MILLION) 149
TABLE 106 ASIA PACIFIC: ANTISCALANTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 150
TABLE 107 ASIA PACIFIC: ANTISCALANTS MARKET, BY PROCESS TYPE, 2020–2023 (KILOTON) 150
TABLE 108 ASIA PACIFIC: ANTISCALANTS MARKET, BY PROCESS TYPE, 2024–2029 (KILOTON) 150
TABLE 109 ASIA PACIFIC: ANTISCALANTS MARKET, BY PROCESS TYPE,
2020–2023 (USD MILLION) 150
TABLE 110 ASIA PACIFIC: ANTISCALANTS MARKET, BY PROCESS TYPE,
2024–2029 (USD MILLION) 151
TABLE 111 ASIA PACIFIC: ANTISCALANTS MARKET, BY APPLICATION, 2020–2023 (KILOTON) 151
TABLE 112 ASIA PACIFIC: ANTISCALANTS MARKET, BY APPLICATION, 2024–2029 (KILOTON) 151
TABLE 113 ASIA PACIFIC: ANTISCALANTS MARKET, BY APPLICATION,
2020–2023 (USD MILLION) 152
TABLE 114 ASIA PACIFIC: ANTISCALANTS MARKET, BY APPLICATION,
2024–2029 (USD MILLION) 152
TABLE 115 CHINA: ANTISCALANTS MARKET, BY APPLICATION, 2020–2023 (KILOTON) 153
TABLE 116 CHINA: ANTISCALANTS MARKET, BY APPLICATION, 2024–2029 (KILOTON) 154
TABLE 117 CHINA: ANTISCALANTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 154
TABLE 118 CHINA: ANTISCALANTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 155
TABLE 119 JAPAN: ANTISCALANTS MARKET, BY APPLICATION, 2020–2023 (KILOTON) 156
TABLE 120 JAPAN: ANTISCALANTS MARKET, BY APPLICATION, 2024–2029 (KILOTON) 156
TABLE 121 JAPAN: ANTISCALANTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 157
TABLE 122 JAPAN: ANTISCALANTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 157
TABLE 123 SOUTH KOREA: ANTISCALANTS MARKET, BY APPLICATION, 2020–2023 (KILOTON) 158
TABLE 124 SOUTH KOREA: ANTISCALANTS MARKET, BY APPLICATION, 2024–2029 (KILOTON) 159
TABLE 125 SOUTH KOREA: ANTISCALANTS MARKET, BY APPLICATION,
2020–2023 (USD MILLION) 159
TABLE 126 SOUTH KOREA: ANTISCALANTS MARKET, BY APPLICATION,
2024–2029 (USD MILLION) 160
TABLE 127 INDIA: ANTISCALANTS MARKET, BY APPLICATION, 2020–2023 (KILOTON) 161
TABLE 128 INDIA: ANTISCALANTS MARKET, BY APPLICATION, 2024–2029 (KILOTON) 162
TABLE 129 INDIA: ANTISCALANTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 162
TABLE 130 INDIA: ANTISCALANTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 163
TABLE 131 REST OF ASIA PACIFIC: ANTISCALANTS MARKET, BY APPLICATION,
2020–2023 (KILOTON) 164
TABLE 132 REST OF ASIA PACIFIC: ANTISCALANTS MARKET, BY APPLICATION,
2024–2029 (KILOTON) 164
TABLE 133 REST OF ASIA PACIFIC: ANTISCALANTS MARKET, BY APPLICATION,
2020–2023 (USD MILLION) 165
TABLE 134 REST OF ASIA PACIFIC: ANTISCALANTS MARKET, BY APPLICATION,
2024–2029 (USD MILLION) 165
TABLE 135 MIDDLE EAST & AFRICA: ANTISCALANTS MARKET, BY COUNTRY,
2020–2023 (KILOTON) 166
TABLE 136 MIDDLE EAST & AFRICA: ANTISCALANTS MARKET, BY COUNTRY,
2024–2029 (KILOTON) 166
TABLE 137 MIDDLE EAST & AFRICA: ANTISCALANTS MARKET, BY COUNTRY,
2020–2023 (USD MILLION) 167
TABLE 138 MIDDLE EAST & AFRICA: ANTISCALANTS MARKET, BY COUNTRY,
2024–2029 (USD MILLION) 167
TABLE 139 MIDDLE EAST & AFRICA: ANTISCALANTS MARKET, BY TYPE, 2020–2023 (KILOTON) 167
TABLE 140 MIDDLE EAST & AFRICA: ANTISCALANTS MARKET, BY TYPE, 2024–2029 (KILOTON) 168
TABLE 141 MIDDLE EAST & AFRICA: ANTISCALANTS MARKET, BY TYPE,
2020–2023 (USD MILLION) 168
TABLE 142 MIDDLE EAST & AFRICA: ANTISCALANTS MARKET, BY TYPE,
2024–2029 (USD MILLION) 168
TABLE 143 MIDDLE EAST & AFRICA: ANTISCALANTS MARKET, BY PROCESS TYPE,
2020–2023 (KILOTON) 169
TABLE 144 MIDDLE EAST & AFRICA: ANTISCALANTS MARKET, BY PROCESS TYPE,
2024–2029 (KILOTON) 169
TABLE 145 MIDDLE EAST & AFRICA: ANTISCALANTS MARKET, BY PROCESS TYPE,
2020–2023 (USD MILLION) 169
TABLE 146 MIDDLE EAST & AFRICA: ANTISCALANTS MARKET, BY PROCESS TYPE,
2024–2029 (USD MILLION) 170
TABLE 147 MIDDLE EAST & AFRICA: ANTISCALANTS MARKET, BY APPLICATION,
2020–2023 (KILOTON) 170
TABLE 148 MIDDLE EAST & AFRICA: ANTISCALANTS MARKET, BY APPLICATION,
2024–2029 (KILOTON) 170
TABLE 149 MIDDLE EAST & AFRICA: ANTISCALANTS MARKET, BY APPLICATION,
2020–2023 (USD MILLION) 171
TABLE 150 MIDDLE EAST & AFRICA: ANTISCALANTS MARKET, BY APPLICATION,
2024–2029 (USD MILLION) 171
TABLE 151 SAUDI ARABIA: ANTISCALANTS MARKET, BY APPLICATION, 2020–2023 (KILOTON) 172
TABLE 152 SAUDI ARABIA: ANTISCALANTS MARKET, BY APPLICATION, 2024–2029 (KILOTON) 173
TABLE 153 SAUDI ARABIA: ANTISCALANTS MARKET, BY APPLICATION,
2020–2023 (USD MILLION) 173
TABLE 154 SAUDI ARABIA: ANTISCALANTS MARKET, BY APPLICATION,
2024–2029 (USD MILLION) 174
TABLE 155 QATAR: ANTISCALANTS MARKET, BY APPLICATION, 2020–2023 (KILOTON) 175
TABLE 156 QATAR: ANTISCALANTS MARKET, BY APPLICATION, 2024–2029 (KILOTON) 176
TABLE 157 QATAR: ANTISCALANTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 176
TABLE 158 QATAR: ANTISCALANTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 177
TABLE 159 UAE: ANTISCALANTS MARKET, BY APPLICATION, 2020–2023 (KILOTON) 178
TABLE 160 UAE: ANTISCALANTS MARKET, BY APPLICATION, 2024–2029 (KILOTON) 178
TABLE 161 UAE: ANTISCALANTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 179
TABLE 162 UAE: ANTISCALANTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 179
TABLE 163 REST OF GCC: ANTISCALANTS MARKET, BY APPLICATION, 2020–2023 (KILOTON) 180
TABLE 164 REST OF GCC: ANTISCALANTS MARKET, BY APPLICATION, 2024–2029 (KILOTON) 181
TABLE 165 REST OF GCC: ANTISCALANTS MARKET, BY APPLICATION,
2020–2023 (USD MILLION) 181
TABLE 166 REST OF GCC: ANTISCALANTS MARKET, BY APPLICATION,
2024–2029 (USD MILLION) 182
TABLE 167 REST OF MIDDLE EAST & AFRICA: ANTISCALANTS MARKET, BY APPLICATION, 2020–2023 (KILOTON) 183
TABLE 168 REST OF MIDDLE EAST & AFRICA: ANTISCALANTS MARKET, BY APPLICATION, 2024–2029 (KILOTON) 183
TABLE 169 REST OF MIDDLE EAST & AFRICA: ANTISCALANTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 184
TABLE 170 REST OF MIDDLE EAST & AFRICA: ANTISCALANTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 184
TABLE 171 SOUTH AMERICA: ANTISCALANTS MARKET, BY COUNTRY, 2020–2023 (KILOTON) 185
TABLE 172 SOUTH AMERICA: ANTISCALANTS MARKET, BY COUNTRY, 2024–2029 (KILOTON) 185
TABLE 173 SOUTH AMERICA: ANTISCALANTS MARKET, BY COUNTRY,
2020–2023 (USD MILLION) 185
TABLE 174 SOUTH AMERICA: ANTISCALANTS MARKET, BY COUNTRY,
2024–2029 (USD MILLION) 186
TABLE 175 SOUTH AMERICA: ANTISCALANTS MARKET, BY TYPE, 2020–2023 (KILOTON) 186
TABLE 176 SOUTH AMERICA: ANTISCALANTS MARKET, BY TYPE, 2024–2029 (KILOTON) 186
TABLE 177 SOUTH AMERICA: ANTISCALANTS MARKET, BY TYPE, 2020–2023 (USD MILLION) 187
TABLE 178 SOUTH AMERICA: ANTISCALANTS MARKET, BY TYPE, 2024–2029 (USD MILLION) 187
TABLE 179 SOUTH AMERICA: ANTISCALANTS MARKET, BY PROCESS TYPE,
2020–2023 (KILOTON) 187
TABLE 180 SOUTH AMERICA: ANTISCALANTS MARKET, BY PROCESS TYPE,
2024–2029 (KILOTON) 187
TABLE 181 SOUTH AMERICA: ANTISCALANTS MARKET, BY PROCESS TYPE,
2020–2023 (USD MILLION) 188
TABLE 182 SOUTH AMERICA: ANTISCALANTS MARKET, BY PROCESS TYPE,
2024–2029 (USD MILLION) 188
TABLE 183 SOUTH AMERICA: ANTISCALANTS MARKET, BY APPLICATION,
2020–2023 (KILOTON) 188
TABLE 184 SOUTH AMERICA: ANTISCALANTS MARKET, BY APPLICATION,
2024–2029 (KILOTON) 189
TABLE 185 SOUTH AMERICA: ANTISCALANTS MARKET, BY APPLICATION,
2020–2023 (USD MILLION) 189
TABLE 186 SOUTH AMERICA: ANTISCALANTS MARKET, BY APPLICATION,
2024–2029 (USD MILLION) 190
TABLE 187 BRAZIL: ANTISCALANTS MARKET, BY APPLICATION, 2020–2023 (KILOTON) 191
TABLE 188 BRAZIL: ANTISCALANTS MARKET, BY APPLICATION, 2024–2029 (KILOTON) 191
TABLE 189 BRAZIL: ANTISCALANTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 192
TABLE 190 BRAZIL: ANTISCALANTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 192
TABLE 191 ARGENTINA: ANTISCALANTS MARKET, BY APPLICATION, 2020–2023 (KILOTON) 193
TABLE 192 ARGENTINA: ANTISCALANTS MARKET, BY APPLICATION, 2024–2029 (KILOTON) 194
TABLE 193 ARGENTINA: ANTISCALANTS MARKET, BY APPLICATION,
2020–2023 (USD MILLION) 194
TABLE 194 ARGENTINA: ANTISCALANTS MARKET, BY APPLICATION,
2024–2029 (USD MILLION) 195
TABLE 195 REST OF SOUTH AMERICA: ANTISCALANTS MARKET, BY APPLICATION,
2020–2023 (KILOTON) 196
TABLE 196 REST OF SOUTH AMERICA: ANTISCALANTS MARKET, BY APPLICATION,
2024–2029 (KILOTON) 196
TABLE 197 REST OF SOUTH AMERICA: ANTISCALANTS MARKET, BY APPLICATION,
2020–2023 (USD MILLION) 197
TABLE 198 REST OF SOUTH AMERICA: ANTISCALANTS MARKET, BY APPLICATION,
2024–2029 (USD MILLION) 197
TABLE 199 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN ANTISCALANTS MARKET BETWEEN 2019 AND 2024 199
TABLE 200 ANTISCALANTS MARKET: DEGREE OF COMPETITION 202
TABLE 201 ANTISCALANTS MARKET: TYPE FOOTPRINT 210
TABLE 202 ANTISCALANTS MARKET: APPLICATION FOOTPRINT 211
TABLE 203 ANTISCALANTS MARKET: PROCESS TYPE FOOTPRINT 212
TABLE 204 ANTISCALANTS MARKET: REGION FOOTPRINT 213
TABLE 205 ANTISCALANTS MARKET: STARTUPS/SMES 216
TABLE 206 ANTISCALANTS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES 217
TABLE 207 ANTISCALANTS MARKET: PRODUCT LAUNCHES, JANUARY 2019–JULY 2024 218
TABLE 208 ANTISCALANTS MARKET: DEALS, JANUARY 2019–JULY 2024 218
TABLE 209 ANTISCALANTS MARKET: EXPANSIONS, JANUARY 2019–JULY 2024 220
TABLE 210 DOW: COMPANY OVERVIEW 224
TABLE 211 DOW: PRODUCTS/SOLUTIONS/SERVICES OFFERED 225
TABLE 212 BASF SE: COMPANY OVERVIEW 228
TABLE 213 BASF SE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 229
TABLE 214 ECOLAB: COMPANY OVERVIEW 232
TABLE 215 ECOLAB: PRODUCTS/SOLUTIONS/SERVICES OFFERED 233
TABLE 216 ECOLAB: DEALS, JANUARY 2019–JULY 2024 234
TABLE 217 ECOLAB: OTHER DEVELOPMENTS, JANUARY 2019–JULY 2024 234
TABLE 218 SOLENIS: COMPANY OVERVIEW 235
TABLE 219 SOLENIS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 236
TABLE 220 SOLENIS: DEALS, JANUARY 2019–JULY 2024 237
TABLE 221 KEMIRA: COMPANY OVERVIEW 239
TABLE 222 KEMIRA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 240
TABLE 223 KEMIRA: DEALS, JANUARY 2019–JULY 2024 241
TABLE 224 KEMIRA: EXPANSIONS, JANUARY 2019–JULY 2024 241
TABLE 225 CLARIANT: COMPANY OVERVIEW 243
TABLE 226 CLARIANT: PRODUCTS/SOLUTIONS/SERVICES OFFERED 244
TABLE 227 CLARIANT: EXPANSIONS, JANUARY 2019–JULY 2024 245
TABLE 228 SYENSQO: COMPANY OVERVIEW 247
TABLE 229 SYENSQO: PRODUCTS/SOLUTIONS/SERVICES OFFERED 248
TABLE 230 SYENSQO: DEALS, JANUARY 2019–JULY 2024 250
TABLE 231 KURITA WATER INDUSTRIES LTD.: COMPANY OVERVIEW 251
TABLE 232 KURITA WATER INDUSTRIES LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 252
TABLE 233 KURITA WATER INDUSTRIES LTD.: EXPANSIONS, JANUARY 2019–JULY 2024 253
TABLE 234 VEOLIA GROUP: COMPANY OVERVIEW 254
TABLE 235 VEOLIA GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED 255
TABLE 236 VEOLIA GROUP: DEALS, JANUARY 2019–JULY 2024 256
TABLE 237 VEOLIA GROUP: EXPANSIONS, JANUARY 2019–JULY 2024 257
TABLE 238 ITALMATCH CHEMICALS S.P.A.: COMPANY OVERVIEW 259
TABLE 239 ITALMATCH CHEMICALS S.P.A.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 260
TABLE 240 ITALMATCH CHEMICALS S.P.A.: PRODUCT LAUNCHES, JANUARY 2019–JULY 2024 262
TABLE 241 ITALMATCH CHEMICALS S.P.A.: DEALS, JANUARY 2019–JULY 2024 263
TABLE 242 BIOLAB ARABIA LTD. CO.: COMPANY OVERVIEW 264
TABLE 243 DUBICHEM: COMPANY OVERVIEW 265
TABLE 244 BAKER HUGHES COMPANY: COMPANY OVERVIEW 266
TABLE 245 REZA INVESTMENT COMPANY LTD.: COMPANY OVERVIEW 267
TABLE 246 NOURYON: COMPANY OVERVIEW 268
TABLE 247 ARIES CHEMICAL, INC.: COMPANY OVERVIEW 268
TABLE 248 OVIVO: COMPANY OVERVIEW 269
TABLE 249 WEATHERFORD: COMPANY OVERVIEW 270
TABLE 250 REDA WATER: COMPANY OVERVIEW 271
TABLE 251 METITO: COMPANY OVERVIEW 271
TABLE 252 AES ARABIA LTD.: COMPANY OVERVIEW 272
TABLE 253 SNF GROUP: COMPANY OVERVIEW 272
TABLE 254 ARKEMA: COMPANY OVERVIEW 273
TABLE 255 ANGEL CHEMICALS PRIVATE LIMITED: COMPANY OVERVIEW 274
TABLE 256 HYDROVIDA: COMPANY OVERVIEW 274
LIST OF FIGURES
FIGURE 1 ANTISCALANTS MARKET SEGMENTATION 25
FIGURE 2 ANTISCALANTS MARKET: RESEARCH DESIGN 30
FIGURE 3 MARKET SIZE ESTIMATION APPROACH: DEMAND SIDE 35
FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 35
FIGURE 5 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 36
FIGURE 6 ANTISCALANTS MARKET: DATA TRIANGULATION 37
FIGURE 7 SULFONATES TYPE SEGMENT TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 41
FIGURE 8 POWER & CONSTRUCTION APPLICATION TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 41
FIGURE 9 THRESHOLD INHIBITOR PROCESS TYPE TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD 42
FIGURE 10 NORTH AMERICA ACCOUNTED FOR LARGEST MARKET SHARE IN 2023 43
FIGURE 11 MARKET IN INDIA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 44
FIGURE 12 ASIA PACIFIC TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 45
FIGURE 13 SULFONATES TO BE FASTEST-GROWING SEGMENT DURING FORECAST PERIOD 45
FIGURE 14 OIL & GAS APPLICATION TO ACCOUNT FOR LARGEST SHARE DURING FORECAST PERIOD 46
FIGURE 15 THRESHOLD INHIBITOR SEGMENT TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 47
FIGURE 16 OIL & GAS AND NORTH AMERICA ACCOUNTED FOR LARGEST MARKET SHARES
IN 2023 47
FIGURE 17 MARKET IN INDIA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 48
FIGURE 18 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN ANTISCALANTS MARKET 50
FIGURE 19 PERCENT-WISE AVAILABILITY OF FRESH WATER IN TOP COUNTRIES 52
FIGURE 20 ANTISCALANTS MARKET: PORTER’S FIVE FORCES ANALYSIS 54
FIGURE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY APPLICATION 56
FIGURE 22 KEY BUYING CRITERIA, BY APPLICATION 57
FIGURE 23 OVERVIEW OF ANTISCALANTS MARKET VALUE CHAIN 58
FIGURE 24 ANTISCALANTS MARKET: ECOSYSTEM ANALYSIS 61
FIGURE 25 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 76
FIGURE 26 IMPORT OF ANTISCALANTS, BY KEY COUNTRY, 2023 77
FIGURE 27 EXPORT OF ANTISCALANTS, BY KEY COUNTRY, 2023 78
FIGURE 28 AVERAGE SELLING PRICE, BY REGION (USD/KG) 81
FIGURE 29 AVERAGE SELLING PRICE, BY TYPE (USD/KG) 82
FIGURE 30 AVERAGE SELLING PRICE, BY APPLICATION (USD/KG) 82
FIGURE 31 AVERAGE SELLING PRICE, BY KEY PLAYER (USD/KG) 83
FIGURE 32 INVESTMENT AND FUNDING SCENARIO 84
FIGURE 33 GRANTED PATENTS ACCOUNTED FOR SIGNIFICANT SHARE OF
ANTISCALANTS MARKET 85
FIGURE 34 NUMBER OF PATENTS YEAR-WISE IN LAST 10 YEARS 85
FIGURE 35 JURISDICTION ANALYSIS 86
FIGURE 36 APPLICANT ANALYSIS 87
FIGURE 37 PHOSPHONATES SEGMENT TO ACCOUNT FOR LARGEST SHARE DURING FORECAST PERIOD 91
FIGURE 38 THRESHOLD INHIBITOR SEGMENT TO ACCOUNT FOR LARGEST SHARE DURING FORECAST PERIOD 96
FIGURE 39 OIL & GAS TO BE LARGEST APPLICATION DURING FORECAST PERIOD 101
FIGURE 40 INDIA TO BE FASTEST-GROWING MARKET DURING FORECAST PERIOD 109
FIGURE 41 NORTH AMERICA: ANTISCALANTS MARKET SNAPSHOT 111
FIGURE 42 EUROPE: ANTISCALANTS MARKET SNAPSHOT 125
FIGURE 43 ASIA PACIFIC: ANTISCALANTS MARKET SNAPSHOT 147
FIGURE 44 SHARE OF LEADING COMPANIES, 2023 202
FIGURE 45 REVENUE ANALYSIS OF KEY COMPANIES, 2023 203
FIGURE 46 COMPANY VALUATION OF LEADING COMPANIES IN ANTISCALANTS MARKET, 2023 205
FIGURE 47 FINANCIAL METRICS OF LEADING COMPANIES IN ANTISCALANTS MARKET, 2023 205
FIGURE 48 ANTISCALANTS MARKET: BRAND/PRODUCT COMPARISON 206
FIGURE 49 ANTISCALANTS MARKET: COMPANY EVALUATION MATRIX, KEY PLAYERS, 2023 208
FIGURE 50 ANTISCALANTS MARKET: COMPANY OVERALL FOOTPRINT 209
FIGURE 51 ANTISCALANTS MARKET: COMPANY EVALUATION MATRIX, STARTUPS/SMES, 2023 215
FIGURE 52 DOW: COMPANY SNAPSHOT 225
FIGURE 53 BASF SE: COMPANY SNAPSHOT 229
FIGURE 54 ECOLAB: COMPANY SNAPSHOT 233
FIGURE 55 KEMIRA: COMPANY SNAPSHOT 240
FIGURE 56 CLARIANT: COMPANY SNAPSHOT 244
FIGURE 57 SYENSQO: COMPANY SNAPSHOT 248
FIGURE 58 KURITA WATER INDUSTRIES LTD.: COMPANY SNAPSHOT 252
FIGURE 59 VEOLIA GROUP: COMPANY SNAPSHOT 255
FIGURE 60 ITALMATCH CHEMICALS S.P.A.: COMPANY SNAPSHOT 260
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11